Hugen N, van de Velde C J H, de Wilt J H W, Nagtegaal I D
Department of Surgery, Radboud university medical center, Nijmegen.
Department of Surgery, Leiden University Medical Center, Leiden.
Ann Oncol. 2014 Mar;25(3):651-657. doi: 10.1093/annonc/mdt591. Epub 2014 Feb 6.
Clinical studies regarding colorectal cancer (CRC) have suggested differences in metastatic patterns between mucinous adenocarcinoma (MC), signet-ring cell carcinoma (SRCC) and the more common adenocarcinoma (AC). The current study systematically evaluates metastatic patterns of different histological subtypes in CRC patients and analyzes metastatic disease upon primary tumor localization.
A nationwide retrospective review of pathological records of 5817 patients diagnosed with CRC who underwent an autopsy between 1991 and 2010 was performed. Patients were selected from the Dutch pathology registry (PALGA). To substantiate clinical relevance, metastatic patterns were compared with the prospective randomized multicenter Total Mesorectal Excision (TME) trial, which investigated efficacy of preoperative radiotherapy in rectal cancer patients.
In the autopsy study, 1675 patients had metastatic disease. MC and SRCC patients more frequently had metastatic disease (33.9% and 61.2% versus 27.6%; P < 0.0001) and had metastases at multiple sites more often compared with AC patients (58.6% and 70.7% versus 49.9%; P = 0.001). AC predominantly metastasized to the liver, and MC and SRCC more frequently had peritoneal metastases. Metastatic patterns were also related to the primary tumor site, with a high rate of abdominal metastases in colon cancer patients, whereas rectal cancer patients more often had metastases at extra-abdominal sites. Results from the TME trial confirmed findings in rectal cancer patients from the autopsy study.
There are profound differences in metastatic patterns between histological subtypes and the localization of the primary tumor in CRC. Findings from this study should encourage to take these factors into account for follow-up strategies and future studies.
关于结直肠癌(CRC)的临床研究表明,黏液腺癌(MC)、印戒细胞癌(SRCC)与更常见的腺癌(AC)之间在转移模式上存在差异。本研究系统评估了CRC患者不同组织学亚型的转移模式,并分析了原发性肿瘤定位后的转移性疾病。
对1991年至2010年间接受尸检的5817例诊断为CRC的患者的病理记录进行了全国性回顾性研究。患者选自荷兰病理登记处(PALGA)。为证实临床相关性,将转移模式与前瞻性随机多中心全直肠系膜切除术(TME)试验进行了比较,该试验研究了术前放疗对直肠癌患者的疗效。
在尸检研究中,1675例患者有转移性疾病。MC和SRCC患者发生转移性疾病的频率更高(分别为33.9%和61.2%,而AC患者为27.6%;P<0.0001),与AC患者相比,多部位转移的情况更常见(分别为58.6%和70.7%,而AC患者为49.9%;P=0.001)。AC主要转移至肝脏,而MC和SRCC更常发生腹膜转移。转移模式也与原发性肿瘤部位有关,结肠癌患者腹部转移率高,而直肠癌患者更常发生腹外部位转移。TME试验结果证实了尸检研究中直肠癌患者的发现。
CRC组织学亚型与原发性肿瘤定位之间在转移模式上存在显著差异。本研究结果应促使在后续策略和未来研究中考虑这些因素。